Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma

NCT04688658 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Secura Bio, Inc. discontinued support of the trial.

Conditions

Unresectable Melanoma

Interventions

DRUG: Nivolumab
DRUG: Duvelisib

Sponsor

John Kirkwood

Collaborators

[object Object]
[object Object]